Amir, Eitan

Delivering affordable cancer care in high-income countries

Sullivan, R., Peppercorn, J., Sikora, K., Zalcberg, J., Meropol, N. J., Amir, E., Khayat, D., Boyle, P., Autier, P., Tannock, I. F., et al. (2011) · The Lancet Oncology

Economic and Financial Impacts of CancerHealth Systems, Economic Evaluations, Quality of Life

Cited by 718

PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

Dupuy, F., Tabariès, S., Andrzejewski, S., Dong, Z., Blagih, J., Annis, M. G., Omeroglu, A., Gao, D., Leung, S., Amir, E., et al. (2015) · Cell Metabolism

Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

Cited by 558

Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer

Amir, E., Miller, N., Geddie, W., Freedman, O., Kassam, F., Simmons, C., Oldfield, M., Dranitsaris, G., Tomlinson, G., Laupacis, A., et al. (2012) · Journal of Clinical Oncology

Breast Cancer Treatment StudiesHER2/EGFR in Cancer Research

Cited by 434

Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer

Vera-Badillo, F. E., Shapiro, R., Ocana, A., Amir, E., & Tannock, I. F. (2013) · Annals of Oncology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 117

Benefit and harms of new anti-cancer drugs

Vera-Badillo, F. E., Al-Mubarak, M., Templeton, A. J., & Amir, E. (2013) · Current Oncology Reports

Statistical Methods in Clinical TrialsHealth Systems, Economic Evaluations, Quality of Life

Cited by 35

The Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Metastatic Testicular Cancer

Ribnikar, D., Stukalin, I., Bedard, P. L., Hamilton, R. J., Jewett, M., Warde, P., Chung, P., Anson-Cartwright, L., Templeton, A. J., Amir, E., et al. (2020) · Current Oncology

Inflammatory Biomarkers in Disease PrognosisTesticular diseases and treatments

Cited by 15